 Shares of Pacific Biosciences of California Inc. shot up 22.3 toward a record in morning trading Wednesday, ahead of the genetic analysis companys fourth-quarter report due out after the closing bell, after the announcement that Japan-based Softbank Group Corp. invested 900 million in the company. The stock has now soared 230.0 over the past three months and skyrocketed 1,051.7 over the past year. 